0001127602-24-009742.txt : 20240312
0001127602-24-009742.hdr.sgml : 20240312
20240312161908
ACCESSION NUMBER: 0001127602-24-009742
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240310
FILED AS OF DATE: 20240312
DATE AS OF CHANGE: 20240312
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Telman Deborah H
CENTRAL INDEX KEY: 0001860008
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 24742322
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES, INC.
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
FORMER COMPANY:
FORMER CONFORMED NAME: GILEAD SCIENCES INC
DATE OF NAME CHANGE: 19930328
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-03-10
0000882095
GILEAD SCIENCES, INC.
GILD
0001860008
Telman Deborah H
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
1
EVP, Corporate Affairs & GC
0
Common Stock
2024-03-10
4
M
0
2555
A
14603
D
Common Stock
2024-03-10
4
F
0
846
75.12
D
13757
D
Restricted Stock Unit
2024-03-10
4
M
0
2555
D
Common Stock
2555
29268
D
Non-qualified Stock Option (Right to Buy)
75.12
2024-03-10
4
A
0
54980
0
A
2034-03-10
Common Stock
54980
54980
D
Restricted Stock Unit
2024-03-10
4
A
0
10815
A
Common Stock
10815
40083
D
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.
The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
The shares subject to the option have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
/s/ Amy Kim by Power of Attorney for Deborah H. Telman
2024-03-12